Indexed with PubMed and Science Citation Index (E) 
Users online: 6822 
     Home | Feedback | Reader Login
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE here  
     Current Issue
     Submit Article 
     My Preferences 
     Dermatology crossword 


Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2004| January-February  | Volume 70 | Issue 1  
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
Immunomodulators in the treatment of psoriasis
Devinder Mohan Thappa, Chandrashekar Laxmisha
January-February 2004, 70(1):1-9
The efficacy of cyclosporine and related drugs in the treatment of psoriasis was the key to the development of the concept that psoriasis is an immune mediated disorder. These therapies demonstrably reduce the number of activated T-lymphocytes, which correlates with clinical remission. Monoclonal antibodies directed against key components of the inflammatory process have been studied in an attempt to produce safer, more effective and selective immunosuppressive agents. This review summarizes the information available on cyclosporine and related drugs, and cytokine therapy, including monoclonal antibodies directed against T-cell mediated inflammation. It should be realized that biologic therapies for psoriasis are very new and that efficacy and safety information from clinical trials is just becoming available.
  13,569 1,098 4
Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care center in South India
David Pudukadan, Devinder Mohan Thappa
January-February 2004, 70(1):20-24
Background: Adverse cutaneous drug reactions (ACDRs) are caused by a wide variety of agents. Aims: Our objective was to ascertain the clinical spectrum of ACDRs and the causative drugs in this part of India and to find any risk factors. Methods: Ninety patients with adverse cutaneous drug reactions were recruited for this study during 2001-2003. Hematological and biochemical investigations were done in all of them. The VDRL and HIV (ELISA) tests were performed where the underlying risk factors were present. Patch testing, intradermal testing and oral provocation tests were done wherever feasible. Results: The mean age of the patients with cutaneous drug eruptions was 37.06 years. Most of them (52.2%) were in the age group of 20-39 years. The male to female ratio was 0.87: 1. The most common eruptions observed were fixed drug eruption (31.1%) and maculopapular rash (12.2%), and the most common causes were co-trimoxazole (22.2%) and dapsone (17.7%). Conclusion: The pattern of ACDRs and the drugs causing them is remarkably different in our population. Knowledge of these drug eruptions, the causative drugs and the prognostic indicators is essential for the clinician.
  12,136 797 12
Hydroxyurea as an alternative therapy for psoriasis
Vinod Kumar Sharma, Bornali Dutta, M Ramam
January-February 2004, 70(1):13-17
Background: Methotrexate is the drug of choice in extensive psoriasis in developing countries. In patients who can not take methotrexate either due to intolerance or concomitant liver disease, there is an urgent need for an alternative affordable and accessible drug. Aims: To evaluate the therapeutic efficacy and safety of hydroxyurea as an alternative in the management of patients with extensive psoriasis. Methods: A prospective study was carried out over 16 months on 34 patients with chronic plaque psoriasis (>20% body surface area involvement), erythrodermic or generalized pustular psoriasis who were partially responsive or non-responsive to the conventional topical and systemic modalities of therapy. Besides doing a baseline hemogram, liver and renal function tests, and urine analysis, these tests were frequently repeated during the course of therapy. Hydroxyurea was started at 1 g daily and increased to 1.5 g, if required. The therapeutic response was evaluated by a global assessment made by the patient and physician and regular PASI scoring. Results: Good to excellent response was observed in 25 (73.5%) patients, less than 50% response in 7 (20.6%) patients, while 2 (5.9%) patients were lost to follow up. The mean PASI score was reduced by 76% at 10-12 weeks. Therapy was discontinued in 3 patients due to leukopenia that recovered on discontinuation of hydroxyurea. Patients were followed up to 1 year and relapse was observed in 5 patients. The duration of remission varied from 6 months to 1 year. Conclusion: Hydroxyurea is an effective and reasonably safe second line agent for psoriasis.
  11,630 333 4
Immunopathogenesis of psoriasis
Rajiv Joshi
January-February 2004, 70(1):10-12
Psoriasis is an immunologically mediated disease caused by activation of T lymphocytes that elaborate a Th1 type of immune response. Targeted manipulation of the various mechanisms involved in T cell activation and blockade or inactivation of the various proinflammatory cytokines released by the process of T cell activation are methods used in treatment of psoriasis by use of ‘biologicals’.
  8,953 818 8
Segmental anhidrosis with hyporeflexia associated with congenital spinal deformity: A Ross’s syndrome variant or inverse Horner’s syndrome?
M PS Sawhney, YK Sharma, N Singh
January-February 2004, 70(1):29-32
A 39-year-old soldier presented with anhidrosis affecting both upper extremities below the shoulders, the right side of the trunk below the third rib in front and the third vertebra on the back, and the left lower extremity below the inguinal ligament since 1992. Ten years later in 2002, he was also found to have bilateral absence of Achilles reflex and decreased right knee jerk. In addition, the patient was found to have congenital spinal abnormalities in the form of block of vertebrae C3-C4; decreased disc space C4-C5; and break in pars interarticularis L5-S1 with decreased disc space. A total of seven cases of Ross syndrome, Holmes-Adie syndrome (tonic pupil with lost tendon jerks) with segmental anhidrosis, have been described in the literature. Our case, however, did not have any pupillary abnormality. A case of progressive isolated segmental anhidrosis has also been described. The association of congenital spinal abnormality, which may be pathognomonic in the causation of this progressive sudomotor degeneration, is quite interesting in our case. The distribution of anhidrosis on the right side is just below the level of sweating loss sometimes described in lesions of superior sympathetic cervical ganglion in Horner’s syndrome.
  9,471 166 1
Hiccups following steroid oral mini-pulse (OMP) therapy
S Chidambara Murthy, MM Udagani
January-February 2004, 70(1):47-47
  8,029 128 1
Serum sickness like reaction with minocycline
Nilendu Sarma, Subrata Malakar, Koushik Lahiri, Uttam Banerjee
January-February 2004, 70(1):43-44
  7,841 136 -
Multicenter, open-label, non-comparative study of a combination of polytar and zinc pyrithione shampoo in the management of dandruff
Shailendra N Sawleshwarkar, Viraj Salgaonkar, Chetan Oberai
January-February 2004, 70(1):25-28
Background: Dandruff is a common condition in clinical practice. We undertook a study to evaluate the efficacy and safety of a combination of zinc pyrithione and polytar in a shampoo base for the treatment of dandruff. Methods: A combination of polytar (1%) and zinc pyrithione (1%) was used for 4 weeks to treat 954 patients suffering from mild to severe dandruff. Scoring of dandruff was done on a 0-10 scale for each of the 6 regions of scalp at weeks 0, 2, 4 and 6. Follow up was for 2 weeks. Results: There was consistent improvement in dandruff scores over the treatment and the follow up period. There was significant improvement in signs and symptoms such as erythema and itching, with a negligible adverse event profile. The global assessment by investigators showed good-excellent results in the majority of patients and there was high acceptability for the treatment among the patients. Conclusion: A combination shampoo of polytar (1%) and zinc pyrithione (1%) offers a safe and effective option in the treatment of dandruff and its associated symptoms.
  7,545 370 3
Pseudolymphoma syndrome revisited
Ashima Goel, R LS Walia
January-February 2004, 70(1):48-51
  7,393 397 1
Sweat function in the diabetic foot
Nirmala Markendeya, Martina V, Anil Mathew, CR Srinivas
January-February 2004, 70(1):18-19
Background: Autonomic dysfunction, an early manifestation of diabetic neuropathy, presents with altered sweating patterns, leading to dryness and fissuring. We conducted a study to assess the sweat function in the diabetic foot and to determine the interrelation between the duration of diabetes, sensation, fissuring, and sweating. Methods: The sweat function was assessed in 30 diabetic patients, 28 of whom had fissuring of the feet, using Ninhydrin impregnated discs. Results: There was a significant association between fissuring and sensation, but not between the duration of diabetes and fissuring and between loss of sweating and fissuring. In 18 patients (60%) there was impairment or absence of sweating in the presence of normal sensation. Conclusion: Although fissuring increases with long-standing diabetes and sweating is reduced in diabetic patients with fissures on the foot, the correlation between these entities was not statistically significant. Since 60% patients had altered sweating in the presence of normal sensations, the sweat test can be used as an early indicator of diabetic neuropathy.
  7,196 168 2
Psoriasis websites
Vinay Gopalani
January-February 2004, 70(1):57-58
  6,614 275 -
Dermatitis recall during disulfiram therapy
Vijay Zawar, Shobha Nerlikar
January-February 2004, 70(1):33-35
We report an alcoholic Indian man, a known case of contact dermatitis to nickel, who presented with recurrence at the same site, without having recent contact with nickel, following disulfiram therapy for his alcohol addiction.
  5,720 108 -
Scleromyxedema with subclinical myositis
P VS Prasad, Joe Mathew Joseph, PK Kaviarasan, P Viswanathan
January-February 2004, 70(1):36-38
A 49-year-old farmer presented with papules on the face, arms, chest and back associated with sclerosis. Histopathology and PAS stain confirmed the clinical diagnosis of scleromyxedema. He also had elevated CPK levels due to myopathy. Screening for internal malignancy was negative.
  5,660 135 1
Flagellate hyperpigmentation from bleomycin
K Pavithran, DC Doval, V Talwar, AK Vaid
January-February 2004, 70(1):46-47
  5,223 110 -
Consumer courts
Subodh P Sirur
January-February 2004, 70(1):52-53
  5,206 103 -
Diabetes mellitus and immunosuppressives
Ramesh Bansal
January-February 2004, 70(1):42-43
  5,145 84 -
Recent advances in dermatology
RG Valia
January-February 2004, 70(1):61-61
  5,012 213 -
Serpiginous lesion on the abdomen
L Padmavathy, L Lakshmana Rao
January-February 2004, 70(1):59-60
  4,982 121 -
Nimesulide induced bullous fixed drug eruption of the labial mucosa
Sendhil Kumaran, Kamaldeep Sandhu, Uma Nahar Saikia, Sanjeev Handa
January-February 2004, 70(1):44-45
  4,789 142 -
Drug interactions of some commonly used drugs in dermatology
MJ Cyriac
January-February 2004, 70(1):54-56
  4,388 261 -
Bullous pemphigoid associated with prostate adenocarcinoma
Serap Öztürkcan, Aylin Türel Ermertcan, Mustafa Turhan Sahin, Peyker Türkdogan, Isil Inanir, Murat Lekili
January-February 2004, 70(1):39-41
Bullous pemphigoid is a common autoimmune skin disease characterized by the presence of subepidermal blisters. It has been associated with underlying neoplasia in isolated reports. A 78-year-old man with generalized blisters was diagnosed as bullous pemphigoid on clinical, histopathological and direct immunofluorescence grounds. His free and total prostate specific antigen (PSA) levels were high and histopathological examination of a prostate specimen revealed prostate adenocarcinoma. We present this rare case to discuss the possible association between bullous pemphigoid and prostate adenocarcinoma.
  2,069 61 2
Online since 15th March '04
Published by Wolters Kluwer - Medknow